Compliance, Math, and Marketers

I spent the day yesterday at eyeforpharma's 3rd Annual Patient Compliance and Adherence Congress in Philadelphia. I went mainly because I was "commissioned" by the conference organizers to be a roundtable moderator on the subject of Direct-to-Patient compliance campaigns. The round table participants discussed new ways to implement a successful direct-to-patient campaign to increase compliance.

This is an example of thinking outside the box and I invite readers to contribute by submitting comments to the blog. It is an issue I'd like to talk about on my podcast (Pharma Marketing Talk) as well. If you are an expert in the area of complinace and have time to talk to me, drop me an email.

For more on this, see today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

• DTC Advertising
• eMarketing
• Unbranded Advertising

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

The collection of articles and commentary in this first Pharma Marketing News Special Supplement chronicles the emerging issues of direct-to-consumer (DTC) advertising and presents pro and con opinions from experts on how DTC needs to adapt in the post-Vioxx marketing era. Topics include: DTC Pros and Cons, Straight-Talking DTC, Communicating Risk, Biotech DTC, Print DTC, and more.

TABLE OF CONTENTS

Order and pay for Volume One now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form